The purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and
safe in the management of children with High Grade Gliomas. Investigators seek to determine
if this imaging will help doctors tell the difference between tumor growth (progression) and
other tumor changes that can occur after treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
Blue Earth Diagnostics, Inc Dragon Master Foundation